… Rosuvastatinassociated adverse effects and drug-drug interactions in the clinical setting of
dyslipidemia. Am J Cardiovasc Drug, 2010; 10(1):11–28. Küskü-Kiraz Z, Mehmetçik G, Dogru-…

… vs potential adverse drug–drug interactions and direct adverse effects (myalgia …
Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of …

… adverse effects, contraindications, and monitoring, of rosuvastatin, so providers can direct
patient therapy in treating hyperlipidemia … Due to the risk of significant drug-drug interactions, …

… First, we analyzed the clinical baseline characteristics and their influences on the Css/D of
RST … To exclude the effects of these clinical baseline features on the Css/D of RST, RSTL, and …

… In spite of their direct cytostatic/cytotoxic effects on the cancer cells, statins via drug
interactions may affect therapeutic effects of the chemotherapy agents and so cause …

… the risk of rosuvastatin-associated myotoxicity [Citation47]. In … with known statin drug-drug
interactions or independently … to provide optimal treatment of hyperlipidemia while avoiding (or …

… indications are homozygous familial hypercholesterolemia, hyperlipidemia, … dyslipidemia,
… benefits, statin therapy may have side effects that should be considered, such as elevated …

… Citation6 Clinicians should consider intensifying statin regimens to improve dyslipidemia …
Hepatic adverse effects are the most known adverse effects induced by statins. Citation8 In …

… their ability to control hyperlipidemia as well as for other pleiotropic effects such as improving
… for these postoperative adverse events, optimal perioperative medical treatment remains …

… statins used for treating various dyslipidemic disorders [4, 5]. … increased risk of ROS-related
adverse events such as low rates of … that a significant drug-drug interaction might result from …